Trade Moderna Inc - MRNA CFD
Add to favourite- Summary
- Historical Data
Spread | 0.23 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 105.56 |
Open | 105.71 |
1-Year Change | -20.96% |
Day's Range | 103.76 - 107.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 26, 2024 | 107.95 | 2.50 | 2.37% | 105.45 | 108.13 | 105.08 |
Apr 25, 2024 | 105.85 | -3.12 | -2.86% | 108.97 | 109.47 | 103.45 |
Apr 24, 2024 | 108.70 | 1.70 | 1.59% | 107.00 | 113.83 | 106.53 |
Apr 23, 2024 | 107.45 | 3.04 | 2.91% | 104.41 | 108.14 | 103.25 |
Apr 22, 2024 | 104.15 | 2.65 | 2.61% | 101.50 | 105.31 | 99.25 |
Apr 19, 2024 | 100.96 | 0.63 | 0.63% | 100.33 | 103.67 | 99.73 |
Apr 18, 2024 | 101.00 | -2.37 | -2.29% | 103.37 | 103.64 | 99.85 |
Apr 17, 2024 | 103.05 | 0.16 | 0.16% | 102.89 | 105.47 | 102.20 |
Apr 16, 2024 | 103.45 | 0.50 | 0.49% | 102.95 | 106.33 | 101.34 |
Apr 15, 2024 | 103.39 | -1.06 | -1.01% | 104.45 | 106.11 | 102.20 |
Apr 12, 2024 | 104.86 | -1.84 | -1.72% | 106.70 | 107.76 | 104.46 |
Apr 11, 2024 | 106.10 | -0.59 | -0.55% | 106.69 | 108.37 | 103.64 |
Apr 10, 2024 | 106.90 | -4.71 | -4.22% | 111.61 | 112.53 | 105.85 |
Apr 9, 2024 | 111.95 | 7.72 | 7.41% | 104.23 | 115.80 | 103.95 |
Apr 8, 2024 | 104.65 | 2.20 | 2.15% | 102.45 | 105.16 | 100.96 |
Apr 5, 2024 | 102.52 | 0.77 | 0.76% | 101.75 | 103.73 | 101.01 |
Apr 4, 2024 | 101.55 | 0.28 | 0.28% | 101.27 | 105.91 | 100.96 |
Apr 3, 2024 | 100.96 | -2.69 | -2.60% | 103.65 | 104.95 | 96.95 |
Apr 2, 2024 | 103.41 | -2.27 | -2.15% | 105.68 | 106.40 | 102.96 |
Apr 1, 2024 | 105.00 | -1.97 | -1.84% | 106.97 | 108.37 | 103.50 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Moderna, Inc. Company profile
Get all the information you need on the Moderna stock price today with Capital.com’s comprehensive chart.
Moderna (MRNA) is a North American clinical-stage biotechnology company. Headquartered in Cambridge, Massachusetts, it specialises in drug discovery and development, as well as vaccine technologies based on messenger RNA (mRNA). The company is working on therapeutics and vaccines for infectious, autoimmune, immuno-oncology and cardiovascular diseases.
Moderna has a number of strategic partnerships with industry-leading names, such as Vertex Pharmaceuticals (VRTX), AstraZeneca (AZN) and Merck & Co (MRK). In 2020, it also worked with Lonza Group (LONN) and Catalent (CTLT) to manufacture its Covid-19 vaccine candidate mRNA-1273. At the end of 2020, the company had 12 programmes in clinical trials and a total of 23 development candidates.
Moderna shares are listed on the Nasdaq Stock Market under the ticker symbol MRNA. The company is a constituent of the NASDAQ-100 Index.
Stay up-to-date with the latest market news and watch the Moderna share price live at Capital.com.
The company was founded in 2010 as Moderna Therapeutics, with the goal of commercialising the research of stem-cell biologist Derrick Rossi. Apart from Rossi, Moderna’s co-founders were Noubar Afeyan, Robert Langer and Kenneth Chien. In August 2018, the company’s name was changed to Moderna.
In November 2020, Moderna’s Covid-19 vaccine candidate, mRNA-1273, showed preliminary evidence of 94.1 per cent efficacy in preventing the disease in a Phase 3 trial. The results led to its submission for emergency use authorisation in the US, Canada and Europe.
In late November, the EU made a deal with Moderna for up to 160 million doses of its vaccine. In December, the US government exercised its option to buy an additional 100 million doses of Moderna’s mRNA-1273, bringing the confirmed order commitment to 200 million doses.
With Capital.com’s Moderna share price chart, you can not only quickly view the current MRNA stock quote, but also trace the company’s share value in historic terms.
Moderna’s long-awaited initial public offering (IPO) happened in December 2018, with the firm selling 26.3 million shares priced at $23 each. At the time, it was the biggest biotech IPO ever. Moderna raised over $600m, valuing the company at $7.5bn (£5.6bn, €6.2bn).
In 2020, MRNA stock has been one of the US market’s best performers. This was due to rising investor enthusiasm over the company’s promising Covid-19 vaccine candidate. After opening the year at $19.57, the MRNA share price was on a hike, peaking at $94.85 in mid July. Within a month, it had dropped to $54.23, but then the stock gained another upside momentum, with its price surging past $100 on November 16. On December 8, the stock closed the trading day at $169.86, representing a year-to-date gain of nearly 770 per cent.
You can go long or short on the company’s shares and trace all the latest ups and downs of the Moderna Inc. stock price using Capital.com’s proprietary trading platform.
Industry: | Biotechnology & Medical Research (NEC) |
200 Technology Sq
CAMBRIDGE
MASSACHUSETTS 02139-3578
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com